Company / Total Assets
Idexx Laboratories Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$3.4B
FY2025
5-year range
$2.4B / $3.4B
FY2021-FY2025
Trend
+1.7%
vs FY2024
Sector context
#77 of 166
Health Care
What the data says
At $3.4B, Idexx Laboratories's total assets ranks #77 of 166 in the Health Care sector. Total Assets has increased for 7 consecutive years, from $1.5B in FY2018 to $3.4B in FY2025.
Based on SEC 10-K filings.
$3.4B in FY2025 with a 5-year CAGR of +7.9%.
Improved from $3.3B to $3.4B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +6.8%
- 5-Year CAGR
- +7.9%
- 10-Year CAGR
- -
Sector benchmark
#77 of 166 in Health CareTop 46% of 166This company $3.4B Sector average $15.0B
▼
-77.6% below sector average
Key checks
Key Insights
- Idexx Laboratories's total assets has grown for 7 consecutive years.
- 5-year CAGR of +7.9%, indicating consistent growth.
- In FY2025, total assets increased 1.7% year-over-year.
- Ranks #77 out of 166 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.4B | +1.7% |
| FY2024 | $3.3B | +1.0% |
| FY2023 | $3.3B | +18.7% |
| FY2022 | $2.7B | +12.7% |
| FY2021 | $2.4B | +6.2% |
| FY2020 | $2.3B | +25.2% |
| FY2019 | $1.8B | +19.2% |
| FY2018 | $1.5B | -10.3% |
| FY2017 | $1.7B | +11.9% |
| FY2016 | $1.5B | +3.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026